CVS Health EVP Capozzi buys shares worth $4588

Heidi B. Capozzi, Executive Vice President and Chief People Officer at CVS Health Corp (NYSE:CVS), has recently purchased a total of 80 shares of the company’s common stock through a trust. The healthcare giant, currently valued at $101 billion, has shown remarkable strength with an 83.5% gain year-to-date according to InvestingPro data. The purchases, executed between September 9 and October 23, 2024, were all acquisitions.

The transactions involved the purchase of shares at prices ranging from $56.47 to $62.24, amounting to a total investment of $4588. Specifically, Capozzi acquired 35 shares on September 9, 10 shares on October 2, and another 35 shares on October 23. The stock currently trades at $79.68, near its 52-week high, and appears undervalued according to InvestingPro’s Fair Value model. Investors seeking deeper insights can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers, covering this and 1,400+ other top US stocks.

In other recent news, CVS Health has been in the spotlight for several significant developments. Cantor Fitzgerald has reiterated its Overweight rating on CVS Health, maintaining a price target of $78.00. The firm highlighted that CVS Health’s Medicare Advantage Star ratings have shown resilience, with over 80% of its ratings at high levels, which is seen as a positive indicator. However, CVS Health is facing challenges as its subsidiary, Omnicare Inc., filed for bankruptcy following a $949 million judgment related to improperly dispensing prescription drugs. The bankruptcy filing lists assets of at least $100 million and liabilities between $1 billion and $10 billion. Additionally, CVS Health is experiencing pressure from Amazon, which announced the expansion of its pharmacy services to include prescription filling at electronic kiosks in its One Medical facilities. Cantor Fitzgerald also pointed out that CVS Health’s involvement in the Arizona market could be negatively impacted by Medicaid disenrollment trends. These recent developments are crucial for investors to consider as they assess CVS Health’s current position and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.